Yahoo Finance senior health reporter Anjalee Khemlani joins Brad Smith on Wealth to discuss the findings, highlighting significant cost increases for key medications, including Merck's (MRK ...

During an R&D update yesterday Merck said it is hoping to claim eight new cardiovascular therapy approvals between now and 2030, for diseases like atherosclerosis, heart failure, pulmonary ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Merck & Co has entered into a worldwide licensing deal with Opko Health’s ModeX Therapeutics unit for a vaccine candidate against Epstein-Barr virus (EBV) that could be worth up to $922.5 ...

There is no Morningstar’s Analysis data available. We sell different types of products and services to both investment professionals and individual investors. These products and services are ...

In November 2024, German exports were up by 2.1% while imports were down by 3.3% on a calendar and seasonally adjusted basis compared with October 2024. Based on provisional data, the Federal ...

Gardasil has recently seen slumping sales in China, where it's being marketed by Merck’s regional commercial partner Zhifei Biological Products. Rob David previously called the expansion to the ...

After hours: 7:57:38 p.m. EST ...